The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Fat and Beyond: The Diverse Biology of PPARγ
Abstract
The nuclear receptor PPARgamma is a ligand-activated transcription factor that plays an important role in the control of gene expression linked to a variety of physiological processes. PPARgamma was initially characterized as the master regulator for the development of adipose cells. Ligands for PPARgamma include naturally occurring fatty acids and the thiazolidinedione (TZD) class of antidiabetic drugs. Activation of PPARgamma improves insulin sensitivity in rodents and humans through a combination of metabolic actions, including partitioning of lipid stores and the regulation of metabolic and inflammatory mediators termed adipokines. PPARgamma signaling has also been implicated in the control of cell proliferation, atherosclerosis, macrophage function, and immunity. Here, we review recent advances in our understanding of the diverse biological actions of PPARgamma with an eye toward the expanding therapeutic potential of PPARgamma agonist drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as PPAR-γ, expressed in adipose tissue, enhances insulin sensitivity, while PPAR-δ, predominantly found in skeletal muscle, supports oxidative metabolism and promotes mitochondrial biogenesis”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [113]
In the citing paper
“Both PPAR-γ and PPAR-δ activation may prove beneficial in maintaining metabolic flexibility during aging”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [113]
In the citing paper
“as PPAR-γ, expressed in adipose tissue, enhances insulin sensitivity, while PPAR-δ, predominantly found in skeletal muscle, supports oxidative metabolism and promotes mitochondrial biogenesis”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [113]
In the citing paper
“the insulinsensitizing effects of thiazolidinediones, a class of PPARg ligands, are used for the treatment of type 2 diabetes mellitus (Tontonoz and Spiegelman, 2008;Hong et al., 2018).”
From The Peroxisome Proliferator–Activated Receptor (PPAR)-γ Antagonist 2-Chloro-5-Nitro-N-Phenylbenzamide (GW9662) Triggers Perilipin 2 Expression via PPARδ and Induces Lipogenesis and Triglyceride Accumulation in Human THP-1 Macrophages (2020) · cites this paper as Tontonoz and Spiegelman, 2008
In the citing paper
“In addition, PPARg exerts considerable effects on lipid and glucose metabolism and insulin sensitivity (Tontonoz and Spiegelman, 2008).”
From The Peroxisome Proliferator–Activated Receptor (PPAR)-γ Antagonist 2-Chloro-5-Nitro-N-Phenylbenzamide (GW9662) Triggers Perilipin 2 Expression via PPARδ and Induces Lipogenesis and Triglyceride Accumulation in Human THP-1 Macrophages (2020) · cites this paper as Tontonoz and Spiegelman, 2008
In the citing paper
“PPARs are activated by a variety of molecules and act mainly as sensors for fatty acids and fatty acid-derived metabolites (Lefebvre et al., 2006;Tontonoz and Spiegelman, 2008;Neels and Grimaldi, 2014).”
From The Peroxisome Proliferator–Activated Receptor (PPAR)-γ Antagonist 2-Chloro-5-Nitro-N-Phenylbenzamide (GW9662) Triggers Perilipin 2 Expression via PPARδ and Induces Lipogenesis and Triglyceride Accumulation in Human THP-1 Macrophages (2020) · cites this paper as Tontonoz and Spiegelman, 2008
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Self-citationXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Self-citationLehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,645
Research works printed but not linked: 7
- Kletzien R, 1992, Mol. Pharmacol., 42, 558
- Harris P, 1994, Mol. Pharmacol., 45, 439
- 10.1210/me.11.6.779 · DOI
- 10.1172/JCI200525102 · DOI · Paper page
- 10.1016/j.expneurol.2006.04.006 · DOI
- 10.1210/en.142.7.3125 · DOI
- Suh N, 1999, Cancer Res., 59, 5671
Cited by
Sorted by citations
Items 701–800 of 1,001
Zhang, Q., You, C., Liu, F., Zhu, W., Wang, S., Xie, D., Monroig, Ó., Tocher, D. R., & Li, Y. (2016) · Lipids · doi:10.1007/s11745-016-4176-3 · Cited by 39
Jin, Y., Yuan, Y., Wu, Q., Zhang, N., Fan, D., Che, Y., Wang, Z., Xiao, Y., Wang, S., & Tang, Q. (2017) · PPAR Research · doi:10.1155/2017/2647129 · Cited by 40
Qi, Y., Sun, L., & Yang, H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.06.016 · Cited by 41
Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis
Korman, B. D., Marangoni, R. G., Lord, G., Olefsky, J. M., Tourtellotte, W. G., & Varga, J. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1630-z · Cited by 40
Lee, J. H., Jang, J. K., Ko, K. Y., Jin, Y., Ham, M., Kang, H., & Kim, I. Y. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0180-x · Cited by 41
Goto, T. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1559025 · Cited by 39
Tilekar, K. N., Hess, J. D., Upadhyay, N., Bianco, A. L., Schweipert, M., Laghezza, A., Loiodice, F., Meyer‐Almes, F., Aguilera, R. J., Lavecchia, A., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00491 · Cited by 40
Roforth, M. M., Liu, G., Khosla, S., & Monroe, D. G. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1502 · Cited by 40
STAT6 Signaling Mediates PPARγ Activation and Resolution of Acute Sterile Inflammation in Mice
Lee, Y.-J., Kim, B.-M., Ahn, Y.-H., Choi, J. H., Choi, Y.-H., & Kang, J. L. (2021) · Cells · doi:10.3390/cells10030501 · Cited by 39
Paciello, F., Pisani, A., Rolesi, R., Escarrat, V., Galli, J., Paludetti, G., Grassi, C., Troiani, D., & Fetoni, A. R. (2021) · Antioxidants · doi:10.3390/antiox10081188 · Cited by 40
Castelino, F. V., & Varga, J. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.848792 · Cited by 39
Lu, K., Han, M., Ting, H. L., Liu, Z., & Zhang, D. (2013) · Journal of Natural Products · doi:10.1021/np300889y · Cited by 39
Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate
Olokpa, E., Moss, P. E., & Stewart, L. V. (2017) · PPAR Research · doi:10.1155/2017/9456020 · Cited by 37
Paciello, F., Fetoni, A. R., Rolesi, R., Wright, M. B., Grassi, C., Troiani, D., & Paludetti, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01103 · Cited by 39
Hung, T., Chu, F.-L., Wu, D., Wu, S., & Huang, C. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1457-2 · Cited by 40
Barone, R. M. E., Rizzo, R., Tabbı̀, G., Malaguarnera, M., Frye, R. E., & Bastin, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081878 · Cited by 40
The ZEB1 Transcription Factor Is a Novel Repressor of Adiposity in Female Mice
Saykally, J. N., Doğan, S., Cleary, M. P., & Sanders, M. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008460 · Cited by 39
Chen, Y., Xue, P., Hou, Y., Zhang, H., Zheng, H., Zhou, T., Qu, W., Teng, W., Zhang, Q., Andersen, M. E., et al. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.005 · Cited by 39
Adiponectin, Adiponectin Receptors, and Epigenetic Regulation of AdipogenesisPreprint
Kadowaki, T., Yamauchi, T., Waki, H., Iwabu, M., Okada‐Iwabu, M., & Nakamura, M. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2012.76.010587 · Cited by 39
Gupta, V., Hammond, C. L., Roztocil, E., Gonzalez, M. O., Feldon, S. E., & Woeller, C. F. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2021.08.010 · Cited by 39
Ren, X., Chang, R. C.-A., Huang, Y., Amato, A. A., Carivenc, C., Grimaldi, M., Kuo, Y., Balaguer, P., Bourguet, W., & Blumberg, B. (2023) · Endocrinology · doi:10.1210/endocr/bqad021 · Cited by 38
Safety of Antidiabetic Therapies on Bone
Lecka‐Czernik, B. (2012) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-012-9129-7 · Cited by 38
Ou, C. Y., Chen, T.-C., Lee, J. V., Wang, J.-C., & Stallcup, M. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.548081 · Cited by 38
Myhrstad, M. C. W., Ulven, S. M., Günther, C., Ottestad, I. O., Holden, M. T. G., Ryeng, E., Borge, G. I. A., Köhler, A., Brønner, K. W., Thoresen, M., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12217 · Cited by 38
Qu, A., Shah, Y. M., Manna, S. K., & Gonzalez, F. J. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.239137 · Cited by 38
Jin, T., Kim, O. Y., Shin, M., Choi, E. Y., Lee, S. S., Han, Y. S., & Chung, J. H. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf502849j · Cited by 38
Iida, M., Katsuno, M., Nakatsuji, H., Adachi, H., Kondo, N., Miyazaki, Y., Tohnai, G., Ikenaka, K., Watanabe, H., Yamamoto, M., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu445 · Cited by 36
Cui, X., Wang, Y., Meng, L., Fei, W., Deng, J., Xu, G., Peng, X., Ju, S., Zhang, L., Liu, C., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00237.2011 · Cited by 38
Panax ginseng Leaf Extracts Exert Anti-Obesity Effects in High-Fat Diet-Induced Obese Rats
Lee, S. G., Lee, Y. J., Jang, M.-H., Kwon, T. R., & Nam, J. (2017) · Nutrients · doi:10.3390/nu9090999 · Cited by 40
Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view
Ferreira, V., Grajales, D., & Valverde, Á. M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158534 · Cited by 41
Endocrine-Disrupting Chemicals and Insulin Resistance in Children
Rotondo, E., & Chiarelli, F. (2020) · Biomedicines · doi:10.3390/biomedicines8060137 · Cited by 43
The forgotten type 2 diabetes mellitus medicine: rosiglitazone
Xu, B., Xing, A., & Li, S. (2021) · Diabetology International · doi:10.1007/s13340-021-00519-0 · Cited by 38
18β-Glycyrrhetinic acid inhibits adipogenic differentiation and stimulates lipolysis.
Moon, M., Jeong, J.-K., Lee, Y.-J., Seol, J., Ahn, D., Kim, I.-S., & Park, S.-Y. (2012) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2012.03.078 · Cited by 37
The interplay between regulatory T cells and metabolism in immune regulation
Zeng, H., & Chi, H. (2013) · OncoImmunology · doi:10.4161/onci.26586 · Cited by 38
The serine/threonine phosphatase PPM1B (PP2Cβ) selectively modulates PPARγ activity
Taşdelen, I., van Beekum, O., Gorbenko, O., Fleskens, V., van den Broek, N. J. F., Koppen, A., Hamers, N., Berger, R., Coffer, P. J., Brenkman, A. B., et al. (2013) · Biochemical Journal · doi:10.1042/bj20121113 · Cited by 38
Choudhary, R., Li, H. Y., Winn, R. A., Sorenson, A. L., Weiser‐Evans, M. C. M., & Nemenoff, R. A. (2010) · Neoplasia · doi:10.1593/neo.91638 · Cited by 39
Mahmoud, A. M., Alexander, M. Y., Tutar, Y., Wilkinson, F. L., & Venditti, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2508909 · Cited by 38
Wang, Y., Wang, X., Du, C., Wang, Z., Wang, J., Zhou, N., Wang, B., Tan, K., Fan, Y., & Cao, P. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1379521 · Cited by 39
What the Genetics of Lipodystrophy Can Teach Us About Insulin Resistance and Diabetes
Vatier, C., Bidault, G., Briand, N., Guénantin, A.-C., Salle-Teyssières, L., Lascols, O., Capeau, J., & Vigouroux, C. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0431-7 · Cited by 37
Enzenbach, C., Kröger, J., Zietemann, V., Jansen, E. H. J. M., Fritsche, A., Döring, F., Boeing, H., & Schulze, M. B. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0169-4 · Cited by 37
Structure Basis of Bigelovin as a Selective RXR Agonist with a Distinct Binding Mode
Zhang, H., Li, L., Chen, L., Hu, L., Jiang, H., & Shen, X. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.01.032 · Cited by 37
Zhang, C., Luo, J., Zheng, P., Yu, B., Huang, Z., Mao, X., He, J., Yu, J., Chen, J., & Chen, D. W. (2015) · animal · doi:10.1017/s1751731115000324 · Cited by 37
Prabhu, S., Vijayakumar, S., Manogar, P., Maniam, G. P., & Govindan, N. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.077 · Cited by 37
Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors
Duszka, K., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082210 · Cited by 37
Mesenteric Adipose Tissue Alterations in Crohn’s Disease Are Associated With the Lymphatic System
Shen, W., Li, Y., Zou, Y., Cao, L., Cai, X., Gong, J., Xu, Y., & Zhu, W. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy306 · Cited by 37
Venkataraman, B., Ojha, S. K., Belur, P. D., Bhongade, B. A., Raj, V., Collin, P. D., Adrian, T. E., & Subramanya, S. B. (2020) · Phytotherapy Research · doi:10.1002/ptr.6625 · Cited by 37
Duszka, K., & Wahli, W. (2020) · Nutrients · doi:10.3390/nu12113476 · Cited by 37
Epigenetic Transgenerational Inheritance of the Effects of Obesogen Exposure
Mohajer, N., Joloya, E. M., Seo, J., Shioda, T., & Blumberg, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.787580 · Cited by 37
Further understanding of fat biology: Lessons from a fat fly
Hong, J., & Park, K. W. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.1.007 · Cited by 37
Ronkainen, P. H. A., Pöllänen, E., Alén, M., Pitkänen, R., Puolakka, J. O., Kujala, U. M., Kaprio, J. A., Sipilä, S., & Kovanen, V. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00636.x · Cited by 37
Phospholipases D1 and D2 Suppress Appetite and Protect against Overweight
Viera, J. T., El‐Merahbi, R., Nieswandt, B., Stegner, D., & Sumara, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157607 · Cited by 37
Luo, H., Zhou, Y., Hu, X., Peng, X., Wei, H., Peng, J., & Jiang, S. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1033594 · Cited by 36
Ali, I. H., Hassan, R. M., Kerdawy, A. M. E., Abo-Elfadl, M. T., Abdallah, H. M. I., Sciandra, F., & Ghannam, I. A. Y. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116279 · Cited by 37
Relaxin signaling activates peroxisome proliferator-activated receptor gamma
Singh, S., & Bennett, R. G. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.014 · Cited by 36
Pang, X., Wei, Y., Zhang, Y., Zhang, M., Lu, Y. Z., & Shen, P. (2013) · Cancer Science · doi:10.1111/cas.12143 · Cited by 36
Lebovic, D. I., Kavoussi, S. K., Lee, J., Banu, S. K., & Arosh, J. A. (2013) · Endocrinology · doi:10.1210/en.2013-1168 · Cited by 36
Metabolic map of osthole and its effect on lipids
Zhao, Q., Li, X., Liu, H., Gonzalez, F. J., & Li, F. (2017) · Xenobiotica · doi:10.1080/00498254.2017.1306660 · Cited by 35
Loh, R. K. C., Formosa, M. F., Eikelis, N., Bertovic, D. A., Anderson, M. J., Barwood, S. A., Nanayakkara, S., Cohen, N. D., Gerche, A. L., Reutens, A. T., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4479-9 · Cited by 36
CACUL1 reciprocally regulates SIRT1 and LSD1 to repress PPARγ and inhibit adipogenesis
Jang, M. J., Park, U., Kim, J. W., Choi, H., Um, S., & Kim, E.-J. (2017) · Cell Death and Disease · doi:10.1038/s41419-017-0070-z · Cited by 36
Pascual‐Serrano, A., Bladé, C., Suárez, M., & Arola‐Arnal, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092632 · Cited by 36
Lin, J., Chen, Y., Tang, W., Liu, C., Zhang, S., Guo, Z., Chen, G., & Zheng, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00063 · Cited by 36
Deng, K., Ren, C., Fan, Y. X., Liu, Z., Zhang, G., Zhang, Y., You, P., & Wang, F. (2019) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2019.106393 · Cited by 35
Creeping fat formation and interaction with intestinal disease in Crohn's disease
Yin, Y. B., Xie, Y., Ge, W., & Li, Y. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12349 · Cited by 40
Youm, Y., Yang, H., Amin, R., Smith, S. R., Leff, T., & Dixit, V. D. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00574.x · Cited by 37
Lee, H. S., Lee, Y. J., Chung, Y. H., Nam, Y., Kim, S. T., Park, E. S., Hong, S. M., Yang, Y. K., Kim, H., & Jeong, J. H. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3259 · Cited by 36
Zhao, Y., Liu, X., Shen, G., Ma, Y., Zhang, F., Chen, M., Zhao, H.-L., Yu, J., & Zhang, J. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.12.010 · Cited by 35
Schubert, M., Becher, S., Wallert, M., Maeß, M. B., Abhari, M., Rennert, K., Mosig, A. S., Große, S., Heller, R., Grün, M., et al. (2020) · Molecular Pharmacology · doi:10.1124/mol.119.117887 · Cited by 35
Engaging plasticity: Differentiation therapy in solid tumors
Bar-Hai, N., & Ishay-Ronen, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.944773 · Cited by 35
Huang, J., Borensztajn, J., & Reddy, J. K. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_10 · Cited by 40
Nakamura, Y., Hinoi, E., Iezaki, T., Takada, S., Hashizume, S., Takahata, Y., Tsuruta, E., Takahashi, S., & Yoneda, Y. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.010 · Cited by 35
Peroxisome Proliferator-Activated Receptor (PPAR): Balance for Survival in Parasitic Infections
Chan, M. M.-Y., Evans, K. W., Moore, A. R., & Fong, D. (2010) · BioMed Research International · doi:10.1155/2010/828951 · Cited by 35
Role of fibroblast growth factors in elicitation of cell responses
Laestander, C., & Engström, W. (2013) · Cell Proliferation · doi:10.1111/cpr.12084 · Cited by 35
Antiadipogenic Effects ofAster glehniExtract: In Vivo and In Vitro Effects
Lee, H.-M., Yang, G., Ahn, T.-G., Kim, M.-D., Nugroho, A., Park, H.-J., Lee, K., Park, W., & An, H. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/859624 · Cited by 35
SR2067 Reveals a Unique Kinetic and Structural Signature for PPARγ Partial Agonism
van Marrewijk, L. M., Polyak, S. W., Hijnen, M., Kuruvilla, D. S., Chang, M. R., Shin, Y., Kamenecka, T. M., Griffin, P. R., & Bruning, J. B. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00580 · Cited by 36
El-Haleim, E. A. A., Bahgat, A. K., & Saleh, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.01.011 · Cited by 35
Obesogens, stem cells and the maternal programming of obesity
Blumberg, B. (2010) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000589 · Cited by 35
Li, J., Zhang, J., & Wang, M. (2016) · Molecules · doi:10.3390/molecules21070810 · Cited by 35
González, F. B., Villar, S. R., Toneatto, J., Pacini, M. F., Márquez, J., D’Attilio, L., Bottasso, O. A., Piwien‐Pilipuk, G., & Pérez, A. R. (2018) · Medical Microbiology and Immunology · doi:10.1007/s00430-018-0572-z · Cited by 36
Almeida, M., Kim, H., Li, H., Zhou, D., Thostenson, J., Porter, R. M., Ambrogini, E., Manolagas, S. C., & Jilka, R. L. (2020) · Aging Cell · doi:10.1111/acel.13247 · Cited by 35
Tissue Resident Foxp3+ Regulatory T Cells: Sentinels and Saboteurs in Health and Disease
Lee, J., Kim, D., & Min, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865593 · Cited by 38
Lee, S., Roeder, R. G., & Lee, J. W. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)87010-5 · Cited by 36
Gao, X., van der Veen, J. N., Hermansson, M., Ordoñez, M., Gómez‐Muñoz, A., Vance, D. E., & Jacobs, R. L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.006 · Cited by 34
Haskew-Layton, R. E., Payappilly, J. B., Xu, H., Bennett, S. A. L., & Ratan, R. R. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12107 · Cited by 35
Xiao, J., Leung, J. C. K., Chan, L. Y. Y., Tang, S. C. W., & Lai, K. N. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.04.004 · Cited by 35
Nuclear Receptors Reverse McGarry's Vicious Cycle to Insulin Resistance
Moore, D. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.016 · Cited by 37
Why do anti-inflammatory therapies fail to improve insulin sensitivity?
Gao, Z., & Ye, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.131 · Cited by 35
Bedi, B., Maurice, N. M., Ciavatta, V. T., Lynn, K. S., Yuan, Z., Molina, S. A., Joo, M., Tyor, W. R., Goldberg, J. B., Koval, M. H., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700075r · Cited by 35
Antibiotics disrupt lipid metabolism in zebrafish (Danio rerio) larvae and 3T3-L1 preadipocytes
Lei, Y., Li, F., Mortimer, M., Li, Z., Peng, B.-X., Li, M., Guo, L., & Zhuang, G. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159755 · Cited by 34
Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
Zhang, M., Liu, C., Ye, L., Li, H., Zhang, W., Liu, J., Wang, L., & Sun, C. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1332205 · Cited by 34
Translational potential of mouse models of human metabolic disease
Farooqi, I. S., & Xu, Y. (2024) · Cell · doi:10.1016/j.cell.2024.07.011 · Cited by 37
Esterson, Y. B., Zhang, K., Koppaka, S., Kehlenbrink, S., Kishore, P., Raghavan, P., Maginley, S. R., Carey, M., & Hawkins, M. (2013) · Journal of Investigative Medicine · doi:10.2310/jim.0000000000000017 · Cited by 34
Bmp4 expressed in preadipocytes is required for the onset of adipocyte differentiation
Suenaga, M., Kurosawa, N., Asano, H., Kanamori, Y., Umemoto, T., Yoshida, H., Murakami, M., Kawachi, H., Matsui, T., & Funaba, M. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.011 · Cited by 34
Nuclear receptors and metabolism: from feast to famine
Hong, S.-H., Ahmadian, M., Yu, R. T., Atkins, A. R., Downes, M., & Evans, R. M. (2014) · Diabetologia · doi:10.1007/s00125-014-3209-9 · Cited by 34
Li, P., Fan, W., Xu, J., Lu, M. M., Yamamoto, H., Auwerx, J. H., Sears, D. D., Talukdar, S., Oh, D., Chen, A., et al. (2011) · Cited by 34
Meneses, M. J., Bernardino, R. L., Sá, R., Silva, J., Barros, A., Sousa, M., Silva, B. M., Oliveira, P. F., & Alves, M. G. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.08.011 · Cited by 36
Frkic, R. L., He, Y., Rodriguez, B. B., Chang, M. R., Kuruvilla, D. S., Ciesla, A., Abell, A. D., Kamenecka, T. M., Griffin, P. R., & Bruning, J. B. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01727 · Cited by 34
Kang, H. S., Lee, J. H., Oh, K., Lee, E., Han, B., Park, K.-Y., Suh, J. M., Min, J., Chi, S., Lee, S. C., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154173 · Cited by 33
Dehdashtian, E., Pourhanifeh, M. H., Hemati, K., Mehrzadi, S., & Hosseinzadeh, A. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3336 · Cited by 35
Li, M., Hu, J., Yao, L., & Gao, M. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15696 · Cited by 34
IL‐17‐induced inflammation modulates the mPGES‐1/PPAR‐γ pathway in monocytes/macrophages
Raucci, F., Saviano, A., Casillo, G. M., Guerra-Rodríguez, M., Mansour, A. A., Piccolo, M., Ferraro, M. G., Panza, E., Vellecco, V., Irace, C., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15413 · Cited by 34
Metadata
- Authors
- Tontonoz, P., & Spiegelman, B. M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Harvard University (US)
- Venue
- Annual Review of Biochemistry
- Publisher
- Annual Reviews
- Published
- 2008-06-01
- Volume
- 77
- Issue
- 1
- Pages
- 289-312
- ISSN
- 0066-4154 (ISSN-L)
- 1545-4509
- OpenAlex
- W2097511872
- Cited by
- 2,085
- References
- 173
- Citations by year
- 2026: 79 · 2025: 100 · 2024: 104 · 2023: 103 · 2022: 111 · 2021: 106 · 2020: 105 · 2019: 108 · 2018: 110 · 2017: 112 · 2016: 135 · 2015: 125 · 2014: 154 · 2013: 160 · 2012: 149
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (R01HL066088, HL66088)
- National Institute of Diabetes and Digestive and Kidney Diseases (R37 DK 3140)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- PPARγ, nuclear receptors, transcriptional regulation, adipose tissue development, thiazolidinediones, insulin sensitivity, adipokines, lipid partitioning, atherosclerosis, macrophage function, immunity, cell proliferation, PPARγ agonists, antidiabetic drugs
- MeSH terms
- Animals, Cell Nucleus, Humans, Inflammation, Insulin Resistance, Macrophages, Models, Biological, Models, Molecular, Neoplasms, Protein Conformation, Protein Structure, Tertiary, Adipocytes, Thiazolidinediones, PPAR gamma, Adipogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review